PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29172833-12	2018	In general, studies comparing treatment outcomes in EGFR-mutated patients and EML4-ALK (ALK) rearranged patients after use of either TA or standard chemotherapy, present significant better results after TA.	Tantalum	133-135	ALK receptor tyrosine kinase	Homo sapiens	78-86	
29172833-12	2018	In general, studies comparing treatment outcomes in EGFR-mutated patients and EML4-ALK (ALK) rearranged patients after use of either TA or standard chemotherapy, present significant better results after TA.	Tantalum	133-135	ALK receptor tyrosine kinase	Homo sapiens	83-86